Parallel Advisors, LLC Guardant Health, Inc. Transaction History

Parallel Advisors, LLC

$4.34 Billion
Q4 2024

A detailed history of Parallel Advisors, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 78 shares of GH stock, worth $3,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 60 30.0%

Holding current value

$3,753

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$20.2 - $38.11 $363 - $685	18 Added 30.0%	78 $2,000
Q3 2024 Nov 13, 2024	SELL	$22.3 - $36.29 $802 - $1,306	-36 Reduced 37.5%	60 $1,000
Q2 2024 Aug 08, 2024	BUY	$16.07 - $31.84 $1,542 - $3,056	96 New	96 $2,000
Q4 2023 Feb 09, 2024	SELL	$21.58 - $29.5 $2,201 - $3,009	-102 Reduced 7.72%	1,219 $32,000
Q3 2023 May 20, 2024	BUY	$25.8 - $39.97 $1,960 - $3,037	76 Added 6.1%	1,321 $39,000
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $1,960 - $3,037	76 Added 6.1%	1,321 $39,000
Q2 2023 May 20, 2024	BUY	$20.94 - $38.01 $2,868 - $5,207	137 Added 12.36%	1,245 $44,000
Q2 2023 Aug 04, 2023	BUY	$20.94 - $38.01 $2,868 - $5,207	137 Added 12.36%	1,245 $44,000
Q1 2023 May 20, 2024	BUY	$22.92 - $33.76 $25,395 - $37,406	1,108 New	1,108 $25,000
Q1 2023 Apr 25, 2023	SELL	$22.92 - $33.76 $595 - $877	-26 Reduced 2.29%	1,108 $25,000
Q4 2022 Feb 03, 2023	BUY	$25.44 - $59.78 $1,729 - $4,065	68 Added 6.38%	1,134 $30,000
Q3 2022 Nov 10, 2022	BUY	$43.66 - $61.0 $29,514 - $41,236	676 Added 173.33%	1,066 $57,000
Q2 2022 Aug 01, 2022	SELL	$28.82 - $77.35 $115 - $309	-4 Reduced 1.02%	390 $16,000
Q1 2022 Apr 28, 2022	BUY	$48.25 - $100.49 $820 - $1,708	17 Added 4.51%	394 $26,000
Q4 2021 Jan 20, 2022	BUY	$88.71 - $120.43 $22,975 - $31,191	259 Added 219.49%	377 $38,000
Q3 2021 Nov 02, 2021	SELL	$98.77 - $132.17 $5,333 - $7,137	-54 Reduced 31.4%	118 $15,000
Q2 2021 Aug 06, 2021	SELL	$109.77 - $165.68 $130,406 - $196,827	-1,188 Reduced 87.35%	172 $21,000
Q1 2021 Apr 23, 2021	SELL	$127.04 - $179.1 $20,961 - $29,551	-165 Reduced 10.82%	1,360 $208,000
Q4 2020 Feb 02, 2021	SELL	$99.96 - $135.93 $10,095 - $13,728	-101 Reduced 6.21%	1,525 $197,000
Q3 2020 Oct 27, 2020	BUY	$80.32 - $111.8 $13,654 - $19,006	170 Added 11.68%	1,626 $182,000
Q2 2020 Jul 16, 2020	SELL	$60.49 - $97.5 $177,235 - $285,675	-2,930 Reduced 66.8%	1,456 $118,000
Q1 2020 Apr 27, 2020	BUY	$59.04 - $88.81 $257,119 - $386,767	4,355 Added 14048.39%	4,386 $305,000
Q2 2019 Aug 05, 2019	BUY	$63.94 - $91.11 $703 - $1,002	11 Added 55.0%	31 $3,000
Q1 2019 May 01, 2019	BUY	$34.3 - $97.98 $686 - $1,959	20 New	20 $2,000

Others Institutions Holding GH

# of Institutions

340

Shares Held

119M

Call Options Held

1.11M

Put Options Held

2.07M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.92B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Guardant Health, Inc. Transaction History